|
breast cancer |
7 |
|
androgen receptor |
6 |
|
bq323636.1 |
6 |
|
tamoxifen resistance |
6 |
|
anastrozole |
3 |
|
ar antagonist |
3 |
|
aromatase inhibitor resistance |
3 |
|
brcaness |
3 |
|
ccrk |
3 |
|
cct241533 |
3 |
|
chk2 |
3 |
|
chk2 inhibitor |
3 |
|
cxcr1 |
3 |
|
dna damage |
3 |
|
doxorubicin resistance |
3 |
|
interleukin-8 |
3 |
|
ivabradine |
3 |
|
ku70 |
3 |
|
nhej |
3 |
|
novel target |
3 |
|
oestrogen receptor |
3 |
|
olaparib |
3 |
|
srpk1 |
3 |
|
srsf5 |
3 |
|
synthetic lethality |
3 |
|
targeted therapy |
3 |
|
tma |
3 |
|
tnbc |
3 |
|
acsl4 |
2 |
|
ak 47 cell line |
2 |
|
biomarker |
2 |
|
breast cancer cell line |
2 |
|
c-myc |
2 |
|
cancer resistance |
2 |
|
chemoresistance |
2 |
|
controlled study |
2 |
|
eif4e |
2 |
|
interleukin-6 |
2 |
|
interleukin-6 receptor |
2 |
|
lipid metabolism |
2 |
|
ncor2 |
2 |
|
novel treatment |
2 |
|
nrf2 |
2 |
|
prognosis |
2 |
|
ribosome biogenesis |
2 |
|
splice variant bq |
2 |
|
tocilizumab |
2 |
|
3-phosphoinositide-dependent protein kinase-1 (pdk1) |
1 |
|
apoptosis |
1 |
|
carcinogenesis |
1 |
|
circulatory |
1 |
|
colon cancer |
1 |
|
colorectal cancer |
1 |
|
colorectal cancer genes |
1 |
|
diagnostic |
1 |
|
drosophila |
1 |
|
escherichia |
1 |
|
expanded-cag rna |
1 |
|
expanded-polyq protein |
1 |
|
fecal |
1 |
|
fusobacterium |
1 |
|
gene regulation |
1 |
|
germ-free |
1 |
|
guanidinate complexes |
1 |
|
huntington's disease |
1 |
|
inflammation |
1 |
|
ion channel |
1 |
|
iron |
1 |
|
machado-joseph disease |
1 |
|
membrane protein (m-protein) |
1 |
|
microbiota |
1 |
|
mir-139-5p |
1 |
|
mirna |
1 |
|
molecular carcinogenesis |
1 |
|
notch1 |
1 |
|
nucleolar stress |
1 |
|
nucleolin |
1 |
|
p3 |
1 |
|
p53 |
1 |
|
pathogen |
1 |
|
patient fibroblast |
1 |
|
polyglutamine disease |
1 |
|
protein kinase b (pkb)/akt |
1 |
|
qbp1 |
1 |
|
r6/2 transgenic mice |
1 |
|
redox chemistry |
1 |
|
rna toxicity |
1 |
|
severe acute respiratory syndrome |
1 |
|
severe acute respiratory syndrome coronavirus (sars-cov) |
1 |
|
signal transduction |
1 |
|
site-directed mutagenesis |
1 |
|
spinocerebellar ataxia |
1 |
|
stool transplantation |
1 |
|
structure elucidation |
1 |
|
synthesis design |
1 |
|
tumor suppressor |
1 |
|
tumour markers |
1 |
|
uce methylation |
1 |
|
vero e6 |
1 |
